4.6 Article

Prognostic relevance of histological variants in nonspecific interstitial pneumonia

Journal

HISTOPATHOLOGY
Volume 65, Issue 4, Pages 549-560

Publisher

WILEY
DOI: 10.1111/his.12415

Keywords

aetiology; non-specific interstitial pneumonia; pathology; survival

Ask authors/readers for more resources

AimsAlthough histological non-specific interstitial pneumonia (NSIP) is concisely defined, overlap with other patterns is described. While most frequently idiopathic, NSIP is seen in various clinical contexts such as connective tissue diseases (CTDs) and chronic hypersensitivity pneumonitis (cHP). This study was designed to determine if NSIP could be separated into subgroups based on minor histological features and to correlate these subgroups with clinical associations and survival. Methods and resultsOne hundred and thirty-six patients with biopsy-proven NSIP were included [clinical diagnosis: CTDs (23%), cHP (12%), idiopathic (65%)]. In addition to the agreed NSIP criteria, seven subgroups were identified: essential NSIP and six overlap subgroups according to superimposed minor histological features. Interobserver concordance resulted in the following consensus: essential NSIP (36%), usual interstitial pneumonia (UIP) overlap (26%), cHP overlap (10%), organizing pneumonia (OP) overlap (6%), organizing diffuse alveolar damage (DAD) overlap (10%), desquamative interstitial pneumonia overlap (7%) and lymphoid interstitial pneumonia overlap (2%). OP overlap was associated with CTDs (P=0.04) and cHP overlap with a cHP clinical diagnosis (P=0.02). Survival was different between subgroups (P=0.0002). Organizing DAD overlap exhibited poorer survival at 5years (32%), followed by UIP overlap (57%). Independent predictors of mortality were organizing DAD overlap (HR=4.99, 95% CI=2.15-11.58, P=0.0002), UIP overlap (HR=2.11, 95% CI=1.12-3.99, P=0.02) and a clinical diagnosis of cHP (HR=2.17, 95% CI=1.05-4.47, P=0.035). ConclusionsNon-specific interstitial pneumonia subdivision into pathological subgroups is clinically relevant from a prognostic and causal perspective.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Rheumatology

Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'

Florence Jeny, Raphael Lhote, Gwenael Lorillon, Nicolas Belhomme, Gregory Pugnet, Raphael Borie, Aurelien Justet, Stephane Jouneau, Nathalie Freymond, Arsene Mekinian, Robin Dhote, Yacine Tandjaoui-Lambiotte, Nathalie Saindenberg, Pierre Gazengel, Baptiste Hervier, Julien Haroche, Alexis Mathian, Miguel Hie, Thibaud Chazal, Dov Taieb, Yurdagul Uzunhan, Jerome Le Pavec, Isabella Annesi-Maesano, Emmanuel Bergot, Abdellatif Tazi, Zahir Amoura, Dominique Valeyre, Hilario Nunes, Fleur Cohen-Aubart

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Surgery

Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort

Mathilde Phillips-Houlbracq, Herve Mal, Vincent Cottin, Clement Gauvain, Fabian Beier, Flore Sicre de Fontbrune, Sabrina Sidali, Jean Francois Mornex, Sandrine Hirschi, Antoine Roux, Gaelle Weisenburger, Arnaud Roussel, Lidwine Wemeau-Stervinou, Jerome Le Pavec, Christophe Pison, Sylvain Marchand Adam, Antoine Froidure, Romain Lazor, Jean-Marc Naccache, Stephane Jouneau, Hilario Nunes, Martine Reynaud-Gaubert, Aurelie Le Borgne, David Boutboul, Ibrahima Ba, Catherine Boileau, Bruno Crestani, Caroline Kannengiesser, Raphael Borie

Summary: This study reviewed the outcomes after lung transplantation in carriers of TRG gene mutations, identifying myelodysplasia and short telomeres as predictors of post-LT survival. All patients experienced anemia, with 66% having thrombocytopenia and 39% having neutropenia post-LT. Hematological evaluation should be conducted systematically before lung transplantation to improve outcomes.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Respiratory System

Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study

Quentin Philippot, Caroline Kannengiesser, Marie Pierre Debray, Clement Gauvain, Ibrahima Ba, Margherita Vieri, Anne Gondouin, Jean-Marc Naccache, Martine Reynaud-Gaubert, Yurdagul Uzunhan, Benjamin Bondue, Dominique Israel-Biet, Philippe Dieude, Cecile Fourrage, Elodie Lainey, Effrosyne Manali, Spyros Papiris, Lidwine Wemeau, Sandrine Hirschi, Herve Mal, Hilario Nunes, Frederic Schlemmer, Elodie Blanchard, Fabian Beier, Vincent Cottin, Bruno Crestani, Raphael Borie

Summary: This study describes the phenotype of patients with interstitial lung disease (ILD) and heterozygous PARN mutations, showing that idiopathic pulmonary fibrosis is common among individuals with PARN mutation. Other ILD subtypes may also be observed, and some patients may experience disease progression leading to death or lung transplantation despite specific treatment.

RESPIROLOGY (2022)

Article Immunology

Overexpression of IgG2 in patients resembling IgG4-related disease with normal IgG4

Mathilde Lecuit, Pierre Aucouturier, Aicha Abbas, Jacques Cadranel, Christine Silvain, Jean-Marie Berthelot, Anne-Laure Fauchais, Paul Loubet, Claude Bachmeyer, Francoise Montravers, Antoine Dossier, Hilario Nunes, Pascale Cervera, Paul Coppo

Summary: IgG4-related disease is characterized by tissue infiltration leading to fibrosis and organomegaly, with clinical presentation varying widely. High serum IgG4 concentration, previously considered a diagnostic hallmark, may not always be present in patients. Elevated IgG2, IgG1, and IgG3 levels were observed in some cases, underscoring the complexity of diagnosing IgG4-RD.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2022)

Article Respiratory System

Exposure to inorganic particles in paediatric sarcoidosis: the PEDIASARC study

Nadia Nathan, Marie-Emeline Montagne, Odile Macchi, Paul-Andre Rosental, Simon Chauveau, Florence Jeny, Lucile Sese, Rola Abou Taam, Manon Brocvielle, Jacques Brouard, Mickael Catinon, Catherine Chapelon-Abric, Fleur Cohen-Aubart, Christophe Delacourt, Celine Delestrain, Antoine Deschildre, Antoine Dossier, Ralph Epaud, Julien Haroche, Veronique Houdouin, Dominique Israel-Biet, Karine Juvin, Sylvain Le Jeune, Francois Lionnet, Ulrich Meinzer, Marie Mittaine, Hilario Nunes, Sarah Mattioni, Jean-Marc Naccache, Marie-Helene Odievre, Michel Vincent, Annick Clement, Dominique Valeyre, Catherine Cavalin

Summary: The study found that pediatric sarcoidosis is associated with patients' indirect exposure to inorganic particles, their family members' occupations, and heating sources, especially factors like construction and metal dust which may increase the risk of the disease.

THORAX (2022)

Article Respiratory System

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension

Laurent Savale, Marloes Huitema, Oksana Shlobin, Vasilis Kouranos, Steven D. Nathan, Hiliaro Nunes, Rohit Gupta, Jan C. Grutters, Daniel A. Culver, Marco C. Post, Daniel Ouellette, Elyse E. Lower, Tamara Al-Hakim, Athol U. Wells, Marc Humbert, Robert P. Baughman

Summary: Sarcoidosis-associated pulmonary hypertension (SAPH) is a significant complication of advanced sarcoidosis. A task force was established to summarize the current knowledge and provide guidance for patient management, including screening and diagnosis. The committee has developed consensus regarding screening and further testing, as well as the need for joint decision-making with experts in sarcoidosis and pulmonary hypertension for specific treatment. However, there are still significant knowledge gaps regarding SAPII that need to be addressed in future studies.

EUROPEAN RESPIRATORY REVIEW (2022)

Article Rheumatology

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

France X. Mariette, O. Hermine, P-L Tharaux, M. Resche-Rigon, R. Porcher, P. Ravaud

Summary: Treatment with sarilumab did not improve early outcomes in patients with moderate-to-severe COVID-19 pneumonia. Further studies are warranted to evaluate the effect of sarilumab on long-term survival.

LANCET RHEUMATOLOGY (2022)

Review Medicine, General & Internal

Comorbidities of sarcoidosis

Claudio Tana, Marjolein Drent, Hilario Nunes, Vasilis Kouranos, Francesco Cinetto, Naomi T. Jessurun, Paolo Spagnolo

Summary: Sarcoidosis is a heterogeneous disease that can affect various organs, and its interaction and coexistence with other diseases can complicate diagnosis and treatment.

ANNALS OF MEDICINE (2022)

Letter Respiratory System

Extracorporeal life support allows lung transplant in anti-MDA5+rapidly progressive interstitial lung disease

Pierre Bay, Marc Pineton de Chambrun, Antoine Roux, Vincent Bunel, Alain Combes, Dominique Israel-Biet, Benjamin Zuber, Hilario Nunes, Yves Allenbach, Yurdagul Uzunhan

EUROPEAN RESPIRATORY JOURNAL (2022)

Editorial Material Infectious Diseases

Air pollution: the silent killer is also indoors

Y. Tandjaoui-Lambiotte, F. Crockett, H. Nunes, I Annesi-Maesano, L. Sese

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2022)

Article Obstetrics & Gynecology

Relaxin-2 during pregnancy according to glycemia, continence status, and pelvic floor muscle function

Caroline Baldini Prudencio, Sthefanie Kenickel Nunes, Fabiane Affonso Pinheiro, Carlos Isaias Sartorao Filho, Flavia Ignacio Antonio, Guilherme Thomaz de Aquino Nava, Marilza Vieira Cunha Rudge, Angelica Mercia Pascon Barbosa

Summary: This study investigates the concentration of relaxin-2 in patients with gestational diabetes mellitus (GDM) and non-GDM during pregnancy, comparing urinary incontinence and pelvic function status. The results show that lower relaxin-2 concentration is associated with the presence of pregnancy-specific urinary incontinence, and the combination of GDM, pregnancy-specific urinary incontinence, and lower levels of pelvic floor strength leads to even lower levels of relaxin-2.

INTERNATIONAL UROGYNECOLOGY JOURNAL (2022)

Article Clinical Neurology

Prognostic value of electroencephalographic paroxysms in post-anoxic coma: A new regularity EEG-based score

Yann Nadjar, Pierre Levy, Vi-Huong Nguyen-Michel, Charles-Edouard Luyt, Louis Puybasset, Vincent Navarro

Summary: This study aimed to identify the features that may predict the outcome of patients with post anoxic coma (PAC) by analyzing electroencephalographic (EEG) patterns. The presence of EEG paroxysms (EP) and their regularity features were strongly associated with poor outcome in PAC patients. A global regularity score derived from visual EEG inspection could be a reliable prognostic tool.

NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY (2022)

Editorial Material Medicine, General & Internal

What do the recent recommendations for the diagnosis and treatment of sarcoidosis mean ?

P. Seve, Y. Jamilloux, A. Bert, T. El Jammal, D. Valeyre

REVUE DE MEDECINE INTERNE (2022)

Article Cardiac & Cardiovascular Systems

Diagnosis Yield and Safety of Surgical Biopsy in Interstitial Lung Diseases: A Prospective Study

Dana Radu, Olivia Freynet, Marianne Kambouchner, Marouane Boubaya, Hilario Nunes, Yurdagul Uzunhan, Pierre-Yves Brillet, Patrice Guiraudet, Mohammad Zaahid Noorah, Dominique Israel-Biet, Francoise Le Pimpec-Barthes, Karine Juvin, Anne Charpentier, Laure Gibault, Jalal Assouad, Jean-Marc Naccache, Martine Antoine, Sebastian Tavolaro, Marco Alifano, Isabelle Honore, Jean Pierre L'Huillier, Denis Debrosse, Clairelyne Dupin, Pauline Pradere, Marie-Pierre Debray, Aurelie Cazes, Pierre Mordant, Yves Castier, Sadek Beloucif, Bruno Crestani, Vincent Levy, Emmanuel Martinod, Dominique Valeyre

Summary: This study prospectively assessed the yield of diagnosis and safety of video-assisted thoracoscopic surgical lung biopsy (VATS-LB) for ILD diagnosis in 103 patients. The results showed that VATS-LB dramatically changed preoperative hypothetical diagnoses and treatment in ILD of unknown cause.

ANNALS OF THORACIC SURGERY (2022)

Article Rheumatology

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses

Paul Breillat, Kuberaka Mariampillai, Paul Legendre, Pauline Martins, Bertrand Dunogue, Jean Luc Charuel, Makoto Miyara, Claire Goulvestre, Romain Paule, Helene Vanquaethem, Felix Ackermann, Olivier Benveniste, Hilario Nunes, Luc Mouthon, Yves Allenbach, Yurdagul Uzunhan

Summary: This study identified three distinct clinical phenotypes and outcomes among patients with anti-PM-Scl-scleroderma antibodies positive autoimmune diseases. Skin thickening and non-specific interstitial pneumonia were crucial predictors in differentiating these subgroups.

RHEUMATOLOGY (2023)

No Data Available